Louisiana-Pacific Corporation (NYSE:LPX) manufactures engineered wood products within the Nyse Composite Index.

MSD has fleshed out its cardiovascular disease pipeline by licensing an oral Lp(a) inhibitor from China's Jiangsu Hengrui Pharma for $200 million upfront. The deal gives MSD exclusive rights to the ...

Eli Lilly's gene-silencing drug lepodisiran has been shown to reduce lipoprotein(a) levels by more than 90% for at least six months with a single injection in a phase 2 trial, reinforcing its ...

Welcome to New Music Friday, your ultimate round-up of this week's single, album and home entertainment releases. Let's get stuck straight into this week's big new single servings. Following his first ...

Chart does not reflect overnight price.